Lucid Diagnostics Inc

Lucid Diagnostics Inc

LUCD

Get informed when a big investor buys or sells

+ Follow
Market Cap$98.94M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lucid Diagnostics IncLucid Diagnostics Inc-2.1--740824%-2.3
$2.00

Target Price by Analysts

107.3% upsideLucid Diagnostics Target Price DetailsTarget Price
$2.12

Current Fair Value

119.3% upside

Undervalued by 119.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$98.94 Million
Enterprise Value$90.44 Million
Dividend Yield$- (-)
Earnings per Share$-0.69
Beta1.07
Outstanding Shares101,947,000

Return

Return on Equity-740824.12%ROE
Return on Assets-207851.52%
Return on Invested Capital-91275.66%

Valuation & Multiples

P/E Ratio-2.08P/E Ratio
PEG-1.27PEG
Price to Sales0.02Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.02
Enterprise Value to EBIT-0.01
Enterprise Value to Net Income-1
Total Debt to Enterprise0.28
Debt to Equity2.28Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 13, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$1.43 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 17, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$1.48 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %34.94% 3.37%
Total Invested$40.96M 16.62%
Investors Holding103 14.00%

ESG Score

No data

About Lucid Diagnostics Inc